Q32 Bio Inc. (QTTB)
(Delayed Data from NSDQ)
$43.48 USD
+4.24 (10.81%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $43.44 -0.04 (-0.09%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Cash flow Statements
Fiscal Year End for Q32 Bio Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -112.96 | -5.01 | -95.76 | -128.69 | -103.92 |
Depreciation/Amortization & Depletion | -2.37 | -0.65 | 9.25 | 7.97 | 6.32 |
Net Change from Assets/Liabilities | -7.21 | 3.35 | -41.80 | 11.52 | 0.46 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 26.31 | -111.35 | 18.57 | 14.88 | 5.78 |
Net Cash From Operating Activities | -96.23 | -113.66 | -109.75 | -94.33 | -91.36 |
Property & Equipment | 0.33 | -1.29 | -2.40 | -3.73 | -21.83 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 130.00 | 0.00 | 0.00 | 0.00 |
Investments | 101.00 | -92.00 | -48.39 | 208.63 | -29.97 |
Other Investing Activities | 0.00 | 130.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 101.33 | 36.72 | -50.79 | 204.90 | -51.80 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.18 | 0.60 | 52.17 | 53.09 | 158.21 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 0.18 | 0.60 | 52.17 | 53.09 | 158.21 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 5.28 | -76.35 | -108.37 | 163.66 | 15.06 |
Cash at Beginning of Period | 33.99 | 110.34 | 218.71 | 55.05 | 39.99 |
Cash at End of Period | 39.27 | 33.99 | 110.34 | 218.71 | 55.05 |
Diluted Net EPS | -35.07 | -1.62 | -31.12 | -50.36 | -44.42 |
Fiscal Year End for Q32 Bio Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -15.95 | 1.03 | -112.96 | -96.84 | -63.89 |
Depreciation/Amortization & Depletion | 0.13 | 0.15 | -2.37 | -1.70 | -1.08 |
Net Change from Assets/Liabilities | -7.33 | -0.58 | -7.21 | 4.34 | 1.20 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -13.62 | -15.16 | 26.31 | 19.55 | 14.05 |
Net Cash From Operating Activities | -36.77 | -14.55 | -96.23 | -74.66 | -49.71 |
Property & Equipment | -0.02 | 0.00 | 0.33 | 0.11 | -0.23 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 10.00 | 0.10 | 101.00 | 69.50 | 92.60 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 9.99 | 0.10 | 101.33 | 69.61 | 92.37 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 42.38 | 42.00 | 0.18 | 0.17 | 0.15 |
Issuance (Repayment) of Debt | 7.00 | 7.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 44.44 | 50.35 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 93.82 | 99.35 | 0.18 | 0.17 | 0.15 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 67.04 | 84.89 | 5.28 | -4.88 | 42.81 |
Cash at Beginning of Period | 31.26 | 31.26 | 33.99 | 33.99 | 33.99 |
Cash at End of Period | 98.31 | 116.16 | 39.27 | 29.11 | 76.80 |
Diluted Net EPS | -1.42 | -6.33 | -4.86 | -10.25 | -10.97 |